ArticleDiabetology & metabolic syndrome2025
Associations of gestational diabetes mellitus with the risk of cardiometabolic diseases: results from NHANES and mendelian randomization analyses.
Article in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundGestational diabetes mellitus (GDM) is associated with an increased risk of long-term cardiometabolic diseases beyond the perinatal period. This study aimed to investigate the association and the potential causality between GDM and subsequent risk of cardiometabolic diseases, as well as to evaluate the effect of GDM onset age on the diseases.
methodsData were from 10,251 women with at least one live birth in the NHANES 2007-2018. Survey-weighted logistic regression analysis was performed to investigate the association. Subsequently, the inverse variance weighted (IVW) and other supplementary approaches of two-sample Mendelian randomization (MR) were used to verify the causal association.
resultsWomen with a history of GDM had an increased risk of obesity (OR: 1.67, 95%CI: 1.38–2.01), hyperlipidemia(OR: 1.28, 95%CI: 1.02 – 1.61), type 2 diabetes mellitus (T2DM) (OR: 5.39, 95%CI: 4.25–6.85), metabolic syndrome (MetS) (OR: 1.62, 95%CI: 1.28–2.05), cardiovascular diseases (OR: 1.61, 95%CI: 1.04–2.52) and coronary heart disease (CHD) (OR: 1.89, 95%CI: 1.17–3.06). Besides, participants diagnosed with GDM at a young age were more prone to developing cardiometabolic diseases. Furthermore, a causal link between GDM and the risk of T2DM (OR: 1.54, 95%CI: 1.09–2.17) and CHD (OR: 1.08, 95%CI: 1.04–1.12) was supported by the IVW method of the MR analysis. Mediation analyses of observational and MR study consistently revealed that T2DM partially mediated the association between GDM and incident CHD.
conclusionsGDM was significantly associated with an increased risk of cardiometabolic diseases, and a younger age of GDM onset indicated a higher risk. Moreover, a causal association of GDM with the risk of T2DM and CHD was identified.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.